Zoledronat Onco Labatec 4 mg/5 ml
Zoledronat Onco Labatec 4 mg/5 ml is a medicine authorised by Swissmedic under authorisation number 63012. The authorisation holder is Labatec Pharma SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 16 April 2013 and the authorisation is valid without a time limit. ATC code M05BA08 places the medicine in the group Drugs for treatment of bone diseases.
| Authorisation number | 63012 |
|---|---|
| Name | Zoledronat Onco Labatec 4 mg/5 ml |
| Full name | Zoledronat Onco Labatec 4 mg/5 ml, solution à diluer pour perfusion |
| Authorisation holder | Labatec Pharma SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | M05BA08 |
| First authorisation | 16 April 2013 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Zoledronat Onco Labatec 4 mg/5 ml, solution à diluer pour perfusion | B | 16 April 2013 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | M05BA08 | 07.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Zoledronat Onco Labatec 4 mg/5 ml authorised in Switzerland?
Yes. Zoledronat Onco Labatec 4 mg/5 ml is authorised by Swissmedic under authorisation number 63012, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Zoledronat Onco Labatec 4 mg/5 ml have?
Zoledronat Onco Labatec 4 mg/5 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Zoledronat Onco Labatec 4 mg/5 ml?
The authorisation holder is Labatec Pharma SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.